13 December American College of Cardiology: Cardiologists Perceptions of Access to New Therapies survey December 13, 2016By CMA Foundation General ACC 0 The American College of Cardiology (ACC) recently published results from its Cardiologists Perceptions of Access to New Therapies survey. The key findings of the survey, which are summarized below, underscore the importance of elevating both the patient and provider voice to eliminate access barriers and ensure timely quality care. Takeaways include: Cardiologists say the top two issues that stand in the way of prescribing the newest evidence-based/guideline-directed therapies are cost (co-payment, co-insurance, deductibles) and administrative burden (prior authorization documentation); Cardiologists would like to see the ACC take a leadership role to reduce the administrative burden; and, Cardiologists are very favorable toward prescribing appropriate new therapies. Not surprisingly, they would be much more inclined to prescribe them if they did not experience delays/denials. For more information on the Cardiologists Perceptions of Access to New Therapies survey and its results visit www.ACC.org. Comments are closed.